Cargando…
2363 Inducing anti-tumor immunity in colorectal cancer
OBJECTIVES/SPECIFIC AIMS: Despite significant advances in screening and treatment, colorectal cancer is the second leading cancer killer in the United States today. Some of the most promising recent developments in cancer therapy have come from immune-based therapy. Immune-based therapy, however, ha...
Autores principales: | Mitchem, Jonathan B., Guan, Yue, Daniels, Mark, Teixeiro, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799605/ http://dx.doi.org/10.1017/cts.2018.87 |
Ejemplares similares
-
3373 Modulation of Hedgehog Signaling Alters Immune Infiltration in Pancreatic Cancer
por: Steele, Nina, et al.
Publicado: (2019) -
2568 Pembrolizumab for patients with leptomeningeal disease from advanced solid tumors
por: Naidoo, Jarushka, et al.
Publicado: (2018) -
3508 Ciclopirox Olamine Demonstrates Inhibitory Effects on Esophageal Tumor Cells
por: Ryan, Randi, et al.
Publicado: (2019) -
3236 Identification of exhaustive markers in cytotoxic T-cells to guide immune modulation in hepatocellular carcinoma ex vivo
por: Krumeich, Lauren Norell, et al.
Publicado: (2019) -
2261 Tumor suppressor RARRES1 regulates cell survival by modulating mitochondrial energetics
por: Maimouni, Sara, et al.
Publicado: (2018)